Cite
MLA Citation
Sakti Chakrabarti et al.. “Fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma: current status, insight on resistance mechanisms and toxicity management.” Expert opinion on drug metabolism and toxicology, vol. 18, 2022, pp. 85–98. http://access.bl.uk/ark:/81055/vdc_100153437081.0x000016